Zimbabwe–UCSF HIV Clinical Trials Unit
UZ-UCSF CTU
This program runs clinical trials of new HIV and TB prevention and treatment approaches for children, adolescents, and adults in Zimbabwe.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11230252 on NIH RePORTER |
What this research studies
The Zimbabwe–UCSF Clinical Trials Unit conducts Phase I–IV trials testing vaccines, antiretrovirals, prevention tools, and care strategies for HIV and TB. It partners with international networks (ACTG, IMPAACT, HPTN, HVTN, MTN) and enrolls people at multiple clinic sites across Zimbabwe. If you join, trained staff will guide you through screening visits, regular follow-ups, and sample collection to monitor safety and how well interventions work. The CTU also trains local researchers and shares findings that help shape national treatment and prevention policies.
Who could benefit from this research
Good fit: Ideal candidates are children, adolescents, or adults in Zimbabwe who have or are at risk for HIV or TB and who meet the specific eligibility rules for a given trial.
Not a fit: People who live outside the CTU clinical sites, who do not meet trial-specific eligibility, or who do not want study procedures are unlikely to benefit directly from participation.
Why it matters
Potential benefit: If successful, the work could lead to better HIV and TB prevention and treatment options and improved care delivery locally and globally.
How similar studies have performed: Similar trials run by global networks have led to effective HIV treatments and prevention tools (for example ART and PrEP), and this CTU has a long track record of enrolling participants and producing influential results.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Chirenje, Zvavahera Mike — University of California, San Francisco
- Study coordinator: Chirenje, Zvavahera Mike
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.